Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 1

Session: Pathogen-specific clinical trials: promise and practical considerations

Gram-negative Trials: Lessons Learned

Saturday, October 2, 2021
10:00 AM - 11:15 AM EDT
Participants should be aware of the following financial/non-financial relationships:
Thomas Lodise, Jr., PharmD, PhD: Melinta Therapeutics (Individual(s) Involved: Self): Consultant; Merck (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator; Paratek (Individual(s) Involved: Self): Consultant; Shionogi (Individual(s) Involved: Self): Consultant, Speakers' bureau; Spero (Individual(s) Involved: Self): Consultant; Tetraphase Pharmaceuticals Inc. (Individual(s) Involved: Self): Consultant

    Speaker(s)

  • Thomas Lodise, Jr., PharmD, PhD

    Professor, Pharmacy Practice
    Albany College of Pharmacy and Health Sciences
    Albany, New York, United States

    Melinta Therapeutics (Individual(s) Involved: Self): Consultant; Merck (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator; Paratek (Individual(s) Involved: Self): Consultant; Shionogi (Individual(s) Involved: Self): Consultant, Speakers' bureau; Spero (Individual(s) Involved: Self): Consultant; Tetraphase Pharmaceuticals Inc. (Individual(s) Involved: Self): Consultant